Journal of Cancer Research and Treatment
ISSN (Print): 2374-1996 ISSN (Online): 2374-2003 Website: Editor-in-chief: Jean Rommelaere
Open Access
Journal Browser
Journal of Cancer Research and Treatment. 2018, 6(1), 1-5
DOI: 10.12691/jcrt-6-1-1
Open AccessCase Report

Complete Cessation of Recurrent Cervical Intraepithelial Neoplasia (CIN) by the Paleolithic Ketogenic Diet: A Case Report

Csaba Tóth1 and Mária Schimmer, Zsófia Clemens1,

1Paleomedicina Hungary Ltd, Evolutionary Medicine Working Group, Budapest, Hungary

Pub. Date: January 05, 2018

Cite this paper:
Csaba Tóth and Mária Schimmer, Zsófia Clemens. Complete Cessation of Recurrent Cervical Intraepithelial Neoplasia (CIN) by the Paleolithic Ketogenic Diet: A Case Report. Journal of Cancer Research and Treatment. 2018; 6(1):1-5. doi: 10.12691/jcrt-6-1-1


Background: Ketogenic diets have repeatedly been suggested for the treatment of cancer. To date, only a few case studies reporting long term benefits associated with such diets have been published. Case report: Here we present a case where recurrent cervical intraepithelial neoplasia (CIN), a premalignant condition of cervical cancer, was successfully treated with the paleolithic ketogenic diet. The patient had a history of high grade CIN in 2011, which was successfully treated with cervical conization and fractional curettage. In October 2015 she was found to have a recurrence of high grade CIN (HSIL: High Grade Squamous Intraepithelial Lesion). The patient was then commenced on the paleolithic ketogenic diet and her repeat Pap (Papanicolaou) smear three months later was found to have reverted to normal. The patient has remained on the paleolithic ketogenic diet for 26 months, her repeat smears have stayed normal, and she is free of symptoms and side effects. Conclusion: We conclude that the diet was effective and safe in this patient. As a major benefit the patient was able to avoid a hysterectomy, which is the standard treatment for recurrent high-grade CIN. We believe that the paleolithic ketogenic diet combines benefits of both paleolithic and classical ketogenic diets, while excluding their disadvantages.

ketosis evolutionary medicine dietary intervention cancer metabolic therapy

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Schmidt M., Pfetzer N, Schwab M, Strauss I, Kämmerer U. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial. Nutr Metab (Lond) 2011; 8: 54.
[2]  Seyfried TN. Cancer as a Metabolic Disease: On the Origin, Management and Prevention of Cancer, John Wiley & Sons, Inc., Hoboken, NJ, USA 2012.
[3]  Warburg O. On the Origin of Cancer Cells. Science, 1956; 123: 309-14.
[4]  Seyfried TN, Flores RE, Poff AM, D’Agostino DP. Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis 2014; 35: 515-527.
[5]  Klement RJ, Sweeney RA. Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients. BMC Research Notes 2016; 9: 143.
[6]  Nebeling LC, Miraldi F, Shurin SB, Lerner E. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr 1995; 14: 202-8.
[7]  Fine EJ, Segal-Isaacson CJ, Feinman RD, Herszkpf S, Romano MC, Tomuta N, et al. Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition 2010; 28: 1028-35.
[8]  Rieger J, Bähr O, Maurer GD, Hattingen E, Franz K, Brucker D, et al. ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 2014; 44: 1843-52.
[9]  Champ, CE, Palmer, JD, Volek, JS, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Shi W. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol 2014; 117: 125-31.
[10]  Tóth C, Clemens Z. Halted progression of soft palate cancer in a patient treated with the paleolithic ketogenic diet alone: A 20-months Follow-up. Am J Med Case Rep 2015; 4: 288-292.
[11]  Cordain L. The paleo diet: lose weight and get healthy by eating the food you were designed to eat. New York: Wiley. 2002.
[12]  Lin JE, Snook AE, Li P, Stoecker BA, Kim GW, Magee MS. GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity. PLoS ONE 2012; 7: 2, e31686.
[13]  Voegtlin WL. The stone age diet: based on in-depth studies of human ecology and the diet of man. New York: Vantage Press 1975.
[14]  Lindeberg S. Food and western disease: health and nutrition from an evolutionary perspective. Chichester: West Sussex, UK, Wiley-Blackwell 2009.
[15]  Jönsson T, Granfeldt Y, Ahrén B, Brannel UC, Pålsson G, Söderström M, et al. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: A randomized cross-over pilot study. Cardiovasc Diabetol 2009; 16, 8: 35.
[16]  Frassetto LA, Schloetter M, Mietus-Synder M, Morris RC Jr, Sebastian A. Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet. Eur J Clin Nutr 2009; 63, 947-55.
[17]  Mellberg C, Sandberg S, Ryberg M, Erickson M, Brage S, Larsson C, et al. Long-term effects of a Palaeolithic-type diet in obese postmenopausal women: A 2-year randomized trial. Eur J Clin Nutr 2014; 68: 3507.
[18]  Boers I., Muskiet FA, Berkelaar E, Schut E, Penders R, Hoenderdos K, et al. Favourable effects of consuming a Palaeolithic-type diet on characteristics of the metabolic syndrome: a randomized controlled pilot-study. Lipids Health Dis 2014; 13: 160.
[19]  Nelson JH, Averette HE, Richart RM. Cervical Intraepithelial Neoplasia (Dysplasia and Carcinoma in Situ) and Early Invasive Cervical Carcinoma. CA Cancer J Clin 1989; 39, 157-178.
[20]  Manheimer EW, van Zuuren EJ, Fedorowicz Z, Pijl H. Paleolithic nutrition for metabolic syndrome: systematic review and meta-analysis. Am J Clin Nutr 2015; 102: 922-32.
[21]  Cordain C. Alfalfa sprouts and autoimmune disease. 2014 http: //, accessed: 30 May 2017
[22]  Tóth C, Dabóczi A. Howard M, Miller NJ, Clemens Z. Crohn’s disease successfully treated with the paleolithic ketogenic diet. Int J Case Rep Images 2016; 7: 570-578.
[23]  Tóth C, Clemens Z. Gilbert’s syndrome successfully treated with the paleolithic ketogenic diet. Am J Med Case Rep 2015; 3: 117-120.
[24]  Tóth C, Clemens Z. Type 1 diabetes mellitus successfully managed with the paleolithic ketogenic diet. Int J Case Rep Images 2014; 5: 699-703.
[25]  Tóth C, Clemens Z. A child with type 1 diabetes mellitus (T1DM) successfully treated with the Paleolithic ketogenic diet: A 19-month insulin freedom. Int J Case Rep Images 2015; 6: 752-757.
[26]  Clemens Z, Kelemen A., Fogarasi A, Tóth C. Childhood absence epilepsy successfully treated with the paleolithic ketogenic diet. Neurol Ther 2013; 2: 71-6.
[27]  Clemens Z, Kelemen A, Tóth C. NREM-sleep Associated Epileptiform Discharges Disappeared Following a Shift toward the Paleolithic Ketogenic Diet in a Child with Extensive Cortical Malformation. Am J Med Case Rep 2015; 3: 212-215.
[28]  Tóth C, Clemens Z. Successful treatment of a patient with obesity, type 2 diabetes and hypertension with the paleolithic ketogenic diet. Int J Case Rep Images 2015; 6: 161-167.
[29]  Tóth C, Clemens Z. Treatment of rectal cancer with the paleolithic ketogenic diet: A 24-months follow-up. Am J Med Case Rep 2017; 5: 205-216.
[30]  Tóth C, Dabóczi A, Chanrai M, Clemens Z. Comment on “Systematic review: isocaloric ketogenic dietary regimes for cancer patients” by Erickson et al. J Cancer Res Treatment. 2017; 5, 86-88.
[31]  Odenwald MA, Turner JR. Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol 2013; 11: 1075-83.
[32]  Coussens LM., Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
[33]  Clemens Z, Tóth C. Vitamin C and Disease: Insights from the Evolutionary Perspective, Journal of Evolution and Health 2016; 1, 1: 13.
[34]  Krone CA, Ely JT. Controlling hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther 2005; 4: 25-31.
[35]  Boros LG., Meuillet EJ, Somlyai I, Jancsó G, Jákli G, Krempels K, et al. Fumarate hydratase and deuterium depletion control oncogenesis via NADPH-dependent reductive synthesis: mitochondrial matrix water, DNA deuteration and epigenetic events. Cancer Research 2014; 74, 19 Supplement: 1426.
[36]  Hao D, Sarfaraz MO, Farshidfar F, Bebb DG, Lee CY, Card CM, David M, Weljie AM. Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment. Metabolomics. 2016; 12: 58.
[37]  Boros LG, Collins TQ, Somlyai G. What to eat or what not to eat-that is still the question. Neuro Oncol. 2017; 19: 595-596.